Breaking News Instant updates and real-time market news.

MCO

Moody's

$156.62

-2.09 (-1.32%)

, BK

BNY Mellon

$50.66

-0.94 (-1.82%)

04:55
11/30/18
11/30
04:55
11/30/18
04:55

Opal Group to hold a summit

CLO Summit 2018 will be held in Dana Point, CA on November 28-30.

MCO

Moody's

$156.62

-2.09 (-1.32%)

BK

BNY Mellon

$50.66

-0.94 (-1.82%)

SSNC

SS&C

$48.51

0.25 (0.52%)

INFO

IHS Markit

$52.81

-0.04 (-0.08%)

RBC

Regal Beloit

$77.49

-0.95 (-1.21%)

BAC

Bank of America

$28.04

-0.4 (-1.41%)

BLK

BlackRock

$423.00

-4.4 (-1.03%)

GS

Goldman Sachs

$194.85

-2.72 (-1.38%)

USB

U.S. Bancorp

$54.05

-0.23 (-0.42%)

C

Citi

$64.90

-0.66 (-1.01%)

SPGI

S&P Global

$180.32

-2.82 (-1.54%)

TRI

Thomson Reuters

$50.03

-0.09 (-0.18%)

ABDC

Alcentra Capital

$6.51

-0.05 (-0.76%)

KYN

Kayne Anderson MLP

$16.08

0.12 (0.75%)

MS

Morgan Stanley

$44.50

-0.82 (-1.81%)

WFC

Wells Fargo

$54.04

-0.31 (-0.57%)

EY

Ethyl

$0.00

(0.00%)

JPM

JPMorgan

$110.06

-0.9 (-0.81%)

COF

Capital One

$88.86

-1.55 (-1.71%)

DB

Deutsche Bank

$9.42

-0.47 (-4.75%)

  • 30

    Nov

  • 30

    Nov

  • 03

    Dec

  • 03

    Dec

  • 04

    Dec

  • 04

    Dec

  • 04

    Dec

  • 05

    Dec

  • 06

    Dec

  • 14

    Jan

  • 29

    Jan

  • 12

    Feb

  • 26

    Feb

  • 13

    Jul

  • 12

    Oct

MCO Moody's
$156.62

-2.09 (-1.32%)

11/14/18
GSCO
11/14/18
INITIATION
Target $165
GSCO
Neutral
Moody's initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst George Tong started Moody's with a Neutral rating and $165 price target.
10/29/18
CANT
10/29/18
NO CHANGE
Target $145
CANT
Neutral
Moody's price target lowered to $145 from $171 at Cantor Fitzgerald
Cantor Fitzgerald analyst Joseph Foresi lowered his price target for Moody's to $145 saying he remains cautious about the "volatile" issuance market. Moody's reported "poor" Q3 results due to the decline in U.S. corporate debt issuance in the period, Foresi tells investors in a research note. The analyst keeps a Neutral rating on the shares.
11/14/18
GSCO
11/14/18
INITIATION
Target $225
GSCO
Buy
Goldman Sachs starts S&P Global at Buy, Moody's at Neutral
As previously reported, Goldman Sachs analyst George Tong started S&P Global (SPGI) with a Buy rating and $225 price target. Tong also started Moody's (MCO) with a Neutral rating and $165 price target. He sees S&P Global and Moody's each having wide and sustainable competitive moats, given their scale and roles as gatekeepers to the debt capital markets, but favors S&P for its diversified business and sustained market share gains at CapIQ. Moody's has greater exposure to debt issuance volume trends, which he believes could introduce near-term volatility, Tong told investors in his initiation note.
10/30/18
PIPR
10/30/18
NO CHANGE
PIPR
Overweight
Rating Agencies 'more appealing' on recent pullback, says Piper Jaffray
Piper Jaffray analyst Peter Appert views the valuations of the Rating Agencies as "more appealing" following the recent selloff. The combination of pricing power, attractive unit volume growth, margin leverage and robust free cash flow can drive sustainable low-to-mid-teens EPS growth for both S&P Global (SPGI) and Moody's (MCO), Appert tells investors in a research note. He admits, however, that cyclical weakness in issuance could keep the stocks in a near-term trading range. The analyst, who believes the "secular growth story remains appealing," has an Overweight rating on S&P Global and Neutral rating on Moody's.
BK BNY Mellon
$50.66

-0.94 (-1.82%)

07/12/18
RAJA
07/12/18
DOWNGRADE
RAJA
Market Perform
BNY Mellon downgraded to Market Perform from Outperform at Raymond James
10/19/18
10/19/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Las Vegas Sands (LVS) downgraded to Buy from Conviction Buy at Goldman Sachs. 2. eBay (EBAY) downgraded to Hold from Buy at Stifel with analyst Scott Devitt saying PayPal's (PYPL) earnings release last night suggested weak eBay gross merchandise volume trends in Q3. 3. Ford (F) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Adam Jonas saying he now believes the market needs more evidence of success before embracing the Ford restructuring story. 4. BNY Mellon (BK) downgraded to Underperform from Market Perform at Keefe Bruyette with analyst Brian Kleinhanzl saying while the company beat estimates this quarter, several line items were weaker than expectations. 5. Harley-Davidson (HOG) downgraded to Market Perform from Outperform at BMO Capital with analyst Gerrick Johnson saying his previously expected catalysts for sales and earnings did not materialize. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/25/18
WOLF
09/25/18
INITIATION
Target $54
WOLF
Underperform
BNY Mellon initiated with an Underperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated BNY Mellon with an Underperform and $54 price target.
10/19/18
KBWI
10/19/18
DOWNGRADE
Target $49
KBWI
Underperform
BNY Mellon downgraded to Underperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl downgraded BNY Mellon to Underperform and lowered his price target for the shares to $49 from $55. While the company beat estimates this quarter, several line items were weaker than expectations, Kleinhanzl tells investors in a research note. He cut his 2019 and 2020 estimates again as a result of limited upside and limited visibility into BNY Mellon's earnings power.
SSNC SS&C
$48.51

0.25 (0.52%)

11/29/18
EVER
11/29/18
INITIATION
Target $74
EVER
Outperform
SS&C resumed with an Outperform at Evercore ISI
Evercore ISI analyst Rayna Kumar resumed coverage of SS&C with an Outperform rating and $74 price target and increased her 2018, 2019 and 2020 EPS estimates to account for the company's Q3 earnings outperformance and the closing of its Intralinks acquisition. Intralinks expands SS&C's offerings in M&A due diligence, capital raising, investor reporting and debt financing while also providing cross sell opportunities, Kumar tells investors.
11/23/18
DBAB
11/23/18
NO CHANGE
DBAB
Deutsche Bank closes short-term Catalyst Call on SS&C
Deutsche Bank analyst Ashish Sabadra closed his short-term Catalyst Call idea on SS&C Technologies. While the company beat Q3 expectations and raised its outlook, the stock remains under pressure due to concerns about high leverage and exposure to the hedge fund industry, Sabadra tells investors in a research note. The analyst, however, believes these headwinds are manageable. SS&C continues to remain a "Fresh Money Idea" for Q4 and Sabadra keeps a Buy rating on the name.
11/16/18
DADA
11/16/18
UPGRADE
Target $58
DADA
Buy
SS&C upgraded to Buy from Neutral at DA Davidson
DA Davidson analyst Peter Heckmann upgraded SS&C to Buy from Neutral as he believes the 20% decline in the stock since early September compensates for the increased risks related to its recent acquisitions of DST Systems and EZE Software as well as its pending deal for Intralinks. Given its 2018 deals, he sees a clear road map for solid growth in EBITDA, EPS and free cash flow into 2020, Heckmann noted. He has a $58 price target on SS&C shares.
11/16/18
JPMS
11/16/18
NO CHANGE
Target $70
JPMS
Overweight
SS&C analyst day 'positive and confident,' says JPMorgan
JPMorgan analyst Jackson Ader found SS&C Technologies' analyst day "positive and confident." The company expects to generate about $1B in free cash flow next year, which the analyst says is slightly ahead of his estimate. He believes this which could produce upside to his 2019 earnings 2019 estimate and continues to view the recent weakness in the shares as a buying opportunity. He has an Overweight rating on SS&C with a $70 price target.
INFO IHS Markit
$52.81

-0.04 (-0.08%)

08/29/18
PIPR
08/29/18
NO CHANGE
PIPR
Piper calls IHS Markit, S&P Global top picks in Information Services
Piper Jaffray analyst Peter Appert calls IHS Markit (IHS) and S&P Global (SPGI) his top picks in the Information Services sector. Dun & Bradstreet's (DNB) pending sale to a private equity group and Nielsen's (NLSN) strategic review refocuses investor attention on M&A activity in the sector, Appert tells investors in a research note. He says that while "rich" transaction values provide an "intriguing valuation backstop for the group," he continues to focus on operating fundamentals as the key driver of stock performance.
10/23/18
BOFA
10/23/18
INITIATION
Target $63
BOFA
Buy
IHS Markit reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Gary Bisbee reinstated coverage on IHS Markit with a Buy and $63 price target saying the company has solid momentum and is trading at a discount to peers. Bisbee expects earnings momentum to be driven by rising auto product growth, energy markets rebound, merger synergies, recent product development investments, and operating efficiency initiatives and called IHS Markit a best idea in the Business and Information Services sector.
09/26/18
RHCO
09/26/18
NO CHANGE
Target $66
RHCO
Buy
IHS Markit price target raised to $66 from $61 at SunTrust
SunTrust analyst Andrew Jeffrey raised his price target on IHS Markit to $66 and kept his Buy rating, saying the company is "positioned to capitalize on leading positions across its markets". The analyst cites IHS Markit's "ongoing global Resources rebound, comprehensive Transportation workflows and an apparently resurgent Financial segment". Jeffrey adds that he expects the company's EBITDA multiples to expand further to match valuations of other information services leaders, raising his FY19 EBITDA view to $1.79B from $1.67B. The analyst further notes that his expected outlook assumes over 400bps of EBITDA margin expansion over the long term.
10/11/18
LEHM
10/11/18
INITIATION
Target $60
LEHM
Overweight
IHS Markit reinstated with an Overweight at Barclays
Barclays analyst Manav Patnaik reinstated coverage of IHS Markit with an Overweight rating and $60 price target following the acquisition of Ipreo. The analyst, who admits that he still struggles to understand the industrial logic behind IHS and Markit's merger of equals back in 2016, says investors have been presented with a diversified "Info" conglomerate that will more often than not produce 5%-7% organic growth, margin expansion and low double-digit earnings growth. He thinks IHS Markit's "ability to compound" in the medium term can continue to win investor support.
RBC Regal Beloit
$77.49

-0.95 (-1.21%)

11/06/18
OPCO
11/06/18
NO CHANGE
Target $90
OPCO
Outperform
Regal Beloit price target lowered to $90 from $95 at Oppenheimer
Oppenheimer analyst Christopher Glynn lowered his price target for Regal Beloit to $90 from $95, considering some pressure on market multiple and transition to lower organic growth, partially offset by continued OM improvement. The analyst reiterates an Outperform rating on the shares.
10/02/18
GSCO
10/02/18
INITIATION
Target $95
GSCO
Buy
Regal Beloit initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Joe Ritchie initiated Regal Beloit with a Buy rating and a price target of $95 as part of his broader research note on SMID industrials that are "setting up for strong end to 2018". The analyst says the stock features "several attractive attributes which include a "good mix of exposure to the cycle and replacement demand, a cost-out story and room to deploy capital in an accretive manner". Ritchie anticipates Regal Beloit's organic annualized growth of 4%-5% through 2020.
11/06/18
BARD
11/06/18
NO CHANGE
Target $91
BARD
Outperform
Regal Beloit remains an undervalued asset, says Baird
Baird analyst Michael Halloran noted Regal Beloit posted strong upside to Q3 results, although revenues were slightly below expectations. He believes the shares are undervalued and he remains a buyer, citing the company's consistent execution against expectations, the company's buybacks with the potential to accelerate, and underlying trends supporting healthy 2019 earnings. Halloran reiterated his Outperform rating and lowered his price target to $91 from $93 on Regal Beloit shares.
11/07/18
BMOC
11/07/18
NO CHANGE
Target $83
BMOC
Market Perform
Regal Beloit price target lowered to $83 from $93 at BMO Capital
BMO Capital analyst R. Scott Graham lowered his price target on Regal Beloit to $83 and kept his Market Perform rating after its Q3 results, saying that while its earnings topped consensus and organic sales grew 5%, the company's international sales slowed. The analyst further notes that he expects Regal Beloit's earnings trends to remain positive, but he also sees them as "largely discounted in the valuation", adding that the company will have to "improve its below-peer margin" to lift its valuation.
BAC Bank of America
$28.04

-0.4 (-1.41%)

09/25/18
WOLF
09/25/18
INITIATION
Target $40
WOLF
Outperform
Bank of America initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated Bank of America with an Outperform and $40 price target.
07/17/18
BARD
07/17/18
NO CHANGE
Target $30
BARD
Neutral
Baird would be buyers of Bank of America on weakness
Baird analyst David George said he would remain a buyer of Bank of America shares on any weakness, stating that its operating leverage was impressive in Q2 and should continue along with solid execution. George maintained his Neutral rating and $30 price target on Bank of America shares.
11/15/18
11/15/18
NO CHANGE

Morgan Stanley says 13F a 'clear signal' of value Buffett sees in financials
Following the release last night of 13F filings detailing the holdings of large investors, including Berkshire Hathaway (BRK.A), Morgan Stanley analyst Kai Pan noted that the filing from Warren Buffett's Berkshire revealed increased stakes in Bank of America (BAC), U.S. Bancorp (USB) and Goldman Sachs (GS) along with new stakes in JPMorgan (JPM), PNC Financial (PNC) and Travelers (TRV). The analyst sees these investments, along with the fact that Berkshire's s financial holdings stood at 46% of its overall $203B equity portfolio as of quarter end, as a "clear signal" of the value that Buffett sees in financials, Pan tells investors. He adds that he views Buffett's new stake in Oracle (ORCL) as another "notable" new purchase.
09/19/18
OPCO
09/19/18
NO CHANGE
OPCO
Outperform
U.S. banks 'in very good shape,' says Oppenheimer, favorites include BofA, Citi
Oppenheimer analyst Chris Kotowski tells investors in a research note that the U.S. banking group is on solid footing with balance sheets less risky than at any time over the last 33 years the firm covered the group and says his favorite bank stocks are Outperform-rated Bank of America (BAC), Citi (C), CIT (CIT) and Goldman Sachs (GS). However, Kotowski notes that banks are trading at an average relative P/E of just ~66% relative to the S&P 500 and returning to a historical avg valuation of 73%-80% range would imply over a thousand basis points of outperformance by the group. In his view, the U.S. banks are, on the whole, in "very good" shape.
BLK BlackRock
$423.00

-4.4 (-1.03%)

11/28/18
JEFF
11/28/18
NO CHANGE
Target $65
JEFF
Buy
Envestnet, BlackRock strategic relationship mutually beneficial, says Jefferies
Jefferies analyst Surinder Thind gives "two thumbs up" to the strategic relationship announced yesterday by Envestnet (ENV) and BlackRock (BLK). Envestnet will accelerate the integration of BlackRock's digital wealth offerings into its platform, while also selling the company a 4.9% stake for $123M, Thind tells investors in a research note. He finds the relationship mutually beneficial saying it provides Envestnet with growth capital and a broader offering that should positively impact its growth rate, while BlackRock gets access to "one of the industry's largest distribution platforms for financial advisors." The analyst lowered his price target for Envestnet to $65 from $70 and keeps a Buy rating on the shares.
11/28/18
DADA
11/28/18
NO CHANGE
Target $62
DADA
Buy
Envestnet partnership with BlackRock an important development, says DA Davidson
DA Davidson analyst Peter Heckmann kept his Buy rating and $62 price target on Envestnet (ENV), saying its strategic relationship with BlackRock (BLK) announced yesterday marks an "important and positive development" for the company. The analyst expects the "deeper technology integration with one of the leading investment management firms" to boost Envestnet's market footprint, allowing them to "continue to add relationships with new advisers". Heckmann adds that the new equity capital coming from BlackRock will give Envestnet more flexibility to pursue M&A.
10/17/18
WELS
10/17/18
NO CHANGE
Target $440
WELS
Market Perform
BlackRock price target lowered to $440 from $510 at Wells Fargo
Wells Fargo analyst Christopher Harris lowered his price target for BlackRock to $440 from $510 after the stock sold off materially likely based on the quarter's revenue, operating income and flow shortfalls and the extent of fee rate degradation. The analyst reiterates a Market Perform rating on the shares.
10/22/18
RBCM
10/22/18
NO CHANGE
Target $95
RBCM
Sector Perform
State Street price target lowered to $95 from $105 at RBC Capital
RBC Capital analyst Gerard Cassidy lowered his price target on State Street (STT) to $95 and kept his Sector Perform rating after its "weak" Q3 results and limited visibility into 2019, also lowering his FY19 EPS view to $1.88 from $2.01. The analyst cites lower than expected profitability metrics that included a 10bp decline in the core ROAA as well as the company's 4.6% shortfall in non-interest income. Cassidy added that State Street is facing continued headwinds of a strengthening USD and the loss of BlackRock (BLK) business weigh on its servicing revenues.
GS Goldman Sachs
$194.85

-2.72 (-1.38%)

11/21/18
11/21/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lowe's (LOW) downgraded to Hold from Buy at Stifel with analyst John Baugh saying the company's "poor" Q3 results indicate near term execution risks are higher and the macro backdrop is unlikely to improve in the near term either. 2. Goldman Sachs (GS) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Betsy Graseck citing the risks and uncertainties related to the bank being investigated for its role in raising funds for 1MDB. 3. Credit Suisse (CS) downgraded to Market Perform from Outperform at Keefe Bruyette. 4. Swatch Group (SWGAY) was downgraded to Sell from Neutral at UBS and to Sector Perform from Outperform at RBC Capital. 5. Alliant Energy (LNT) downgraded to Underperform from Neutral at BofA/Merrill with analyst Julien Dumoulin-Smith citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/21/18
MSCO
11/21/18
DOWNGRADE
MSCO
Equal Weight
Goldman Sachs downgraded to Equal Weight from Overweight at Morgan Stanley
11/21/18
11/21/18
DOWNGRADE
Target $226

Equal Weight
Goldman Sachs downgraded to Equal Weight on 1MDB probe risks at Morgan Stanley
As previously reported, Morgan Stanley analyst Betsy Graseck downgraded Goldman Sachs to Equal Weight from Overweight, citing the risks and uncertainties related to the bank being investigated for its role in raising funds for 1MDB. It is currently unclear how long the issue will take to resolve, what the fines and penalties could be and what costs Goldman will incur, said Graseck, who doesn't see the stock's multiple expanding significantly until the 1MDB issue is resolved. She lowered her price target on Goldman Sachs shares to $226 from $291.
USB U.S. Bancorp
$54.05

-0.23 (-0.42%)

11/27/18
11/27/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Hormel Foods (HRL) downgraded to Hold from Buy at Jefferies with analyst Akshay Jagdale citing valuation. 2. Wyndham Hotels & Resorts (WH) downgraded to Buy from Conviction Buy at Goldman Sachs while Wyndham Destinations (WYND) was downgraded to Neutral from Buy. 3. U.S. Bancorp (USB) downgraded to Hold from Buy at Deutsche Bank with analyst Matthew O'Connor citing valuation. 4. Macerich (MAC) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Richard Hill saying he believes the market is underappreciating the company's free cash flow declines in 2019 and 2020. 5. Athenahealth (ATHN) downgraded to Market Perform from Outperform at Wells Fargo with analyst Jamie Stockton saying he suspects a proxy will come out in the next week or two detailing the full process since June to try to sell the company, which ultimately resulted in Veritas Capital and Elliott Management making a $135 all-cash offer on November 12. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/19/18
PIPR
11/19/18
NO CHANGE
Target $62
PIPR
Overweight
U.S. Bancorp positioned to become 'best-in-class' again, says Piper Jaffray
After meeting with management, Piper Jaffray analyst Kevin Barker has increased conviction U.S. Bancorp will generate "meaningful" operating leverage in 2019 and likely continue into 2020 despite industry-wide revenue headwinds. The company appears poised to see expense growth moderate while conditions appear positive for several fee income line items, Barker tells investors in a research note. The analyst believes U.S. Bancorp is in a position to regain the "'best-in-class' crown it once wore for several years." He raised his price target for the shares to $62 from $61 and reiterates an Overweight rating on the name.
11/26/18
DBAB
11/26/18
DOWNGRADE
Target $63
DBAB
Hold
U.S. Bancorp downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Matthew O'Connor downgraded U.S. Bancorp to Hold with an unchanged price target of $63.
11/26/18
DBAB
11/26/18
DOWNGRADE
Target $63
DBAB
Hold
Deutsche Bank downgrades U.S. Bancorp to Hold on valuation
Deutsche Bank analyst Matthew O'Connor downgraded U.S. Bancorp to Hold from Buy with an unchanged price target of $63. The stock closed the trading day up 64c to $54.16. U.S. Bancorp now trades at a nearly 20% premium to peers given its improving operating leverage, up sharply from a low in the summer of a modest discount, O'Connor tells investors in a research note. While the analyst remains positive on the bank from a fundamental standpoint, he does not expect strong relative outperformance going forward given the current valuation.
C Citi
$64.90

-0.66 (-1.01%)

08/28/18
WELS
08/28/18
NO CHANGE
Target $100
WELS
Outperform
Citi to benefit from potential U.S.-Mexico trade deal, says Wells Fargo
Wells Fargo analyst Mike Mayo believes Citi could gain more than other large U.S. banks from a U.S.-Mexico trade deal given its ownership of the second largest bank in Mexico, Citibanamex. In his view, Citi's stock had been hurt on perceptions of the U.S. relationship with Mexico. At a minimum, any new trade deal could reflect the absence of a negative and, on the upside, new potential growth opportunities, he contends. Mayo reiterates an Outperform rating and $100 price target on the shares.
10/15/18
BMOC
10/15/18
NO CHANGE
Target $92
BMOC
Market Perform
Citi price target raised to $92 from $85 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Citi to $92 in spite of its Q3 earnings miss as he rolls his valuation model forward by a quarter. The analyst also notes that its lower expected revenues are being offset by lower costs while pointing to "cheap" valuation for financials in spite of the rising interest rates which are positive for net interest margins and better employment which is positive for credit. Fotheringham keeps his Market Perform rating for Citi, stating that some of its peers offer an even "greater opportunity".
09/25/18
WOLF
09/25/18
INITIATION
Target $91
WOLF
Outperform
Citi initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated Citi with an Outperform and $91 price target.
SPGI S&P Global
$180.32

-2.82 (-1.54%)

11/14/18
GSCO
11/14/18
INITIATION
Target $225
GSCO
Buy
S&P Global initiated with a Buy at Goldman Sachs
Goldman Sachs analyst George Tong started S&P Global with a Buy rating and $225 price target.
10/09/18
UBSW
10/09/18
NO CHANGE
UBSW
Buy
Ratings agencies Q3 estimates still too high, says UBS
UBS analyst Alex Kramm adjusted his estimates for the rating agencies ahead of Q3 results but still remains below Street expectations for both Moody's (MCO) and S&P Global (SPGI). He likes the setup for better refi activity in 2019, but he expects continued choppiness in the near-term on the back of rising rates and volatility.
TRI Thomson Reuters
$50.03

-0.09 (-0.18%)

10/18/18
GSCO
10/18/18
INITIATION
GSCO
Neutral
Thomson Reuters reinstated with a Neutral at Goldman Sachs
Goldman Sachs analyst George King reinstated Thomson Reuters with a Neutral and $49 price target saying valuation reflects stable Legal and Tax business and cost take-out opportunities.
10/18/18
10/18/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) initiated with an Outperform at Wedbush. 2. BJ's Wholesale (BJ) initiated with a Perform at Oppenheimer. 3. Comcast (CMCSA) initiated with an Outperform at Evercore ISI. 4. Thomson Reuters (TRI) reinstated with a Neutral at Goldman Sachs. 5. Atomera (ATOM) initiated with a Buy at Roth Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/13/18
MSCO
09/13/18
UPGRADE
MSCO
Overweight
Thomson Reuters upgraded to Overweight from Equal Weight at Morgan Stanley
08/28/18
ADAM
08/28/18
NO CHANGE
Target $45
ADAM
Buy
Thomson Reuters buyback plans generally in line with Canaccord expectations
Canaccord analyst Aravinda Galappatthige said Thomson Reuters' plans to repurchase up to $9B of shares at a price between $42 and $47 is generally in line with his expectations in terms of size and the indicated premium. The analyst, who keeps a Buy rating on the stock, said his $45 price target already factors in the impact of this buyback and the decrease in debt.
ABDC Alcentra Capital
$6.51

-0.05 (-0.76%)

01/11/18
RAJA
01/11/18
UPGRADE
RAJA
Market Perform
Alcentra Capital upgraded to Market Perform at Raymond James
Raymond James analyst Robert Dodd upgraded Alcentra Capital to Market Perform telling investors the shift in strategy focus to more secure, higher credit quality assets will benefit shareholders in the long-rum.
01/11/18
RAJA
01/11/18
UPGRADE
RAJA
Market Perform
Alcentra Capital upgraded to Market Perform from Underperform at Raymond James
KYN Kayne Anderson MLP
$16.08

0.12 (0.75%)

08/09/18
BOFA
08/09/18
DOWNGRADE
BOFA
Neutral
Kayne Anderson MLP downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Derek Walker downgraded Kayne Anderson MLP (KYN) to Neutral from Buy following the merger with Kayne Anderson Energy (KED).
MS Morgan Stanley
$44.50

-0.82 (-1.81%)

10/24/18
10/24/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Lockheed Martin (LMT) upgraded to Conviction Buy from Neutral at Goldman Sachs with analyst Noah Poponak raising his price target for the shares to $394 from $391. 2. Paccar (PCAR) upgraded to Overweight from Neutral at Piper Jaffray with analyst Alexander Potter saying Paccar's brands boasted the highest level of brand loyalty in his firm's survey of 743 U.S.-based fleets. 3. Morgan Stanley (MS) upgraded to Outperform from Market Perform at Wells Fargo with analyst Mike Mayo saying this means he now recommends 5 out of 5 of the largest U.S. wholesale banks. 4. 3D Systems (DDD) upgraded to Neutral from Underweight at Piper Jaffray with analyst Troy Jensen saying while Piper's Q3 survey "showed another poor performance" from 3D Systems' resellers, the company's "significant direct sales win" with Align Technology (ALGN) will continue to allow 3D Systems to report "impressive" year-over-year product growth for the next few quarters. 5. Lululemon (LULU) upgraded to Buy from Hold at Canaccord with analyst Camilo Lyon saying he recommends taking advantage of the recent 15% pullback as he believes the risk/reward is now skewed to the upside. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/24/18
10/24/18
UPGRADE
Target $60

Outperform
Wells Fargo goes 'all-in' on U.S. global banks, ups Morgan Stanley to Outperform
As previously reported, Wells Fargo analyst Mike Mayo upgraded Morgan Stanley (MS) to Outperform from Market Perform, noting that this means he now recommends 5 out of 5 of the largest U.S. wholesale banks. Morgan Stanley has evolved its business mix more than any other large bank, having increased its wealth and asset management to half of the firm, said Mayo, who sees the bank's EPS beating consensus by 2020 even assuming only 5% total revenue growth over that period. Mayo expects Morgan Stanley to increase its financial targets in January and believes it should fare better under the next CCAR in June, he added. Mayo raised his price target on Morgan Stanley shares to $60 from $56.
10/24/18
WELS
10/24/18
UPGRADE
WELS
Outperform
Morgan Stanley upgraded to Outperform from Market Perform at Wells Fargo
10/16/18
OPCO
10/16/18
UPGRADE
Target $62
OPCO
Outperform
Oppenheimer upgrades Morgan Stanley to Outperform after 'clean beat'
Oppenheimer analyst Chris Kotowski upgraded Morgan Stanley to Outperform from Perform with a $62 price target following this morning's Q3 results. The stock in morning trading is up 4%, or $1.67, to $45.13. Morgan Stanley continues to perform well, "and the market has not cared about this," Kotowski tells investors in a research note titled "Stock Down, Earnings Up!" The analyst views the Q3 report as a "clean beat" and upped his 2019 earnings per share estimate to $5.17 from $5.04 as a result. Despite a string of estimate upticks, shares of Morgan Stanley are down 25% since early March, Kotowski points out. He thinks the market's attitude that it is late in the cycle and that financial stocks "are not safe at any price" will prove wrong.
WFC Wells Fargo
$54.04

-0.31 (-0.57%)

10/15/18
BMOC
10/15/18
NO CHANGE
Target $65
BMOC
Market Perform
Wells Fargo price target raised to $65 from $61 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Wells Fargo to $65 in spite of its Q3 revenue miss as he raises his FY19 EPS view by 1c to $5.23 to reflect lower expected credit costs. The analyst also notes that financials are "cheap again" in spite of the rising interest rates which are positive for net interest margins, better employment which is positive for credit, and regulatory relief which is positive for their capital position. Fotheringham also keeps his Market Perform rating on Wells Fargo, saying that while the bank's valuation is getting "cheap" for the first time since he launched coverage, better opportunities exist in other large-cap financials.
11/02/18
SBSH
11/02/18
UPGRADE
SBSH
Buy
Wells Fargo upgraded to Buy from Neutral at Citi
Citi analyst Keith Horowitz upgraded Wells Fargo to Buy.
10/15/18
MACQ
10/15/18
UPGRADE
MACQ
Outperform
Wells Fargo upgraded to Outperform from Neutral at Macquarie
10/15/18
10/15/18
UPGRADE
Target $62

Outperform
Wells Fargo upgraded to Outperform, visibility improving, says Macquarie
As previously reported, Macquarie upgraded Wells Fargo to Outperform from neutral with a $62 price target. Analyst David Konrad said Wells Fargo shares are trading at a 10% discount to peers and believes investors will warm up to the company's self-help story of meaningful expense savings over the next two years combined with better than peer buybacks. Konrad notes revenue growth will be challenging, but is encouraged by signs from consumers in the form of improved checking account and card growth, and moderating FA turnover.
EY Ethyl
$0.00

(0.00%)

JPM JPMorgan
$110.06

-0.9 (-0.81%)

10/15/18
BMOC
10/15/18
NO CHANGE
Target $124
BMOC
Market Perform
JPMorgan price target raised to $124 from $118 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on JPMorgan to $124 after its Q3 earnings beat driven by lower than expected loan loss provision. The analyst notes that financials are "cheap again" in spite of the rising interest rates which are positive for net interest margins, better employment which is positive for credit, and regulatory relief which is positive for their capital position. Fotherinham also keeps his Market Perform rating on JPMorgan, saying its two-year forward earnings multiple is "only slightly" below its long-term historical average.
10/16/18
JANY
10/16/18
NO CHANGE
JANY
Buy
Janney Montgomery Scott says On Deck's new unit hints at new bank partnerships
After On Deck Capital (ONDK) announced earlier that it has created a new wholly owned subsidiary, ODX, that will provide technology and other services to banks looking to lend online to small businesses, Janney Montgomery Scott analyst John Rowan said he sees this as the logical step before the company announces one or more new bank partnerships. While he thinks the company's lone existing bank partnership, with JPMorgan (JPM), is not a profit center, Rowan believes that the economics could improve as each new bank partner comes on-board and he thinks ODX could eventually become a profit center for On Deck. He maintains a Buy rating on the stock.
10/03/18
BERN
10/03/18
NO CHANGE
BERN
Amazon to be accelerant of disruption coming for healthcare, says Bernstein
Bernstein analyst Lance Wilkes believes disruption is coming for healthcare and that Amazon (AMZN) will be an accelerant of this disruption. Further, the analyst sees a parallel with the fast changes in health insurance which took place in the 90's, when health insurance changed from 90% indemnity to 80% managed care within ten years. Wilkes thinks Amazon is developing a series of business strategies for entering healthcare market segments, namely directly entering online pharmacy, creating a disruptor in the employer healthcare space through its venture with Berkshire (BRK.A) and JPMorgan (JPM), and entering digital consumer healthcare spaces including using Alexa for consumer engagement and behavior modification.
COF Capital One
$88.86

-1.55 (-1.71%)

11/16/18
OPCO
11/16/18
NO CHANGE
Target $114
OPCO
Outperform
American Express new top credit card pick, says Oppenheimer
Oppenheimer analyst Dominick Gabriele said his new top pick in the credit card space is American Express (AXP) vs. Capital One (COF), as he sees more levers to drive EPS growth upside. In a research note to investors, Gabriele says TTM delinquency formation trends among his credit card coverage reflect a benign credit environment while net charge offs are likely to remain subdued.
10/24/18
BMOC
10/24/18
NO CHANGE
Target $146
BMOC
Outperform
Capital One price target raised to $146 from $135 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Capital One to $146 and kept his Outperform rating after its "credit-driven" Q3 earnings beat. The analyst cites lower than expected loan loss provision and higher net interest income, adding that the stock offers a "very meaningful" re-rating potential.
10/31/18
MSCO
10/31/18
NO CHANGE
MSCO
Morgan Stanley sees BB&T, AmEx as possible winners if Fed changes bank rules
Noting that the Federal Reserve will release a memo detailing proposed changes to bank capital rules to the public around 10 am today and is scheduled to vote on this proposal in a meeting starting at 10:30 am, Morgan Stanley analyst Betsy Graseck said BB&T (BBT) could be the biggest beneficiary with a 5% EPS increase if it is ruled that banks with more than $250B in assets that are not Global Systemically Important Banks should have more tailored regulation. Other potential beneficiaries of possible rule changes include American Express (AXP), Capital One (COF), Northern Trust (NTRS), PNC Financial (PNC) and U.S. Bancorp (USB), Graseck added.
10/24/18
SDLR
10/24/18
NO CHANGE
Target $115
SDLR
Buy
Capital One price target raised to $115 after earnings beat at Sandler O'Neill
Sandler O'Neill analyst Christopher Donat raised his 2018, 2019 and 2020 EPS estimates for Capital One after the company's Q3 core EPS beat, which he was driven by a lower than expected provision for credit losses and net interest income that increased 4% from Q2. Separate from the earnings release, Capital One disclosed that its domestic card net charge off ratio was 4.13% in September, which was below Donat's expectation of 4.46%. He views the year-over-year charge off decrease as further evidence of "the end of the negative parts of growth math," added Donat. He raised his price target on Capital One shares to $115 from $113 and keeps a Buy rating on the shares.
DB Deutsche Bank
$9.42

-0.47 (-4.75%)

08/10/18
MSCO
08/10/18
DOWNGRADE
MSCO
Underweight
Deutsche Bank downgraded to Underweight from Equal Weight at Morgan Stanley
08/10/18
08/10/18
DOWNGRADE

Underweight
Morgan Stanley cuts Deutsche Bank to Underweight on limited top-line visibility
As previously reported, Morgan Stanley analyst Magdalena Stoklosa downgraded Deutsche Bank to Underweight from Equal Weight, stating that while she gives management "full credit" for its cost cutting efforts, it is hard to have any visibility on the top line. She assumes 2018-20 revenue CAGR of just 1.5%, which is below the average for Eurozone banks and below managements target of 4%. While recognizing the risk of downgrading Deutsche Bank "at the bottom," Stoklosa sees current conditions as unlikely to be conducive to a near-term re-rating, she tells investors. She has an EUR9 target on the bank's shares.
06/01/18
RBCM
06/01/18
DOWNGRADE
RBCM
Underperform
Deutsche Bank downgraded to Underperform from Sector Perform at RBC Capital
08/13/18
BOFA
08/13/18
DOWNGRADE
Target $9
BOFA
Underperform
Deutsche Bank downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Andrew Stimpson downgraded Deutsche Bank to Underperform from Neutral saying he expects the earnings downgrade cycle to continue given CIB revenue headwinds.

TODAY'S FREE FLY STORIES

SG

Sirius International Insurance Group

$7.75

0.4 (5.44%)

15:50
11/13/19
11/13
15:50
11/13/19
15:50
Periodicals
Sirius International 'pitched for sale,' Insurance Insider reports »

Sirius International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$51.35

4.34 (9.23%)

15:45
11/13/19
11/13
15:45
11/13/19
15:45
Options
CrowdStrike Holdings call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

QGEN

Qiagen

$32.98

0.72 (2.23%)

, TMO

Thermo Fisher

$298.97

2.89 (0.98%)

15:43
11/13/19
11/13
15:43
11/13/19
15:43
Hot Stocks
Qiagen shares surge as Thermo Fisher reportedly weighs purchase »

Shares of Qiagen (QGEN)…

QGEN

Qiagen

$32.98

0.72 (2.23%)

TMO

Thermo Fisher

$298.97

2.89 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 07

    Dec

QGEN

Qiagen

$33.09

0.83 (2.57%)

15:39
11/13/19
11/13
15:39
11/13/19
15:39
Hot Stocks
Breaking Hot Stocks news story on Qiagen 

Qiagen trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

CTAS

Cintas

$254.89

-4.01 (-1.55%)

15:38
11/13/19
11/13
15:38
11/13/19
15:38
Recommendations
Cintas analyst commentary  »

Cintas management offers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$298.79

2.71 (0.92%)

, QGEN

Qiagen

$33.03

0.77 (2.39%)

15:35
11/13/19
11/13
15:35
11/13/19
15:35
Periodicals
Thermo Fisher considering purchase of Qiagen, Bloomberg reports »

Thermo Fisher has…

TMO

Thermo Fisher

$298.79

2.71 (0.92%)

QGEN

Qiagen

$33.03

0.77 (2.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 07

    Dec

QGEN

Qiagen

$33.03

0.77 (2.39%)

15:34
11/13/19
11/13
15:34
11/13/19
15:34
Hot Stocks
Breaking Hot Stocks news story on Qiagen »

Qiagen trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

PUMP

ProPetro Holding

$7.49

-0.21 (-2.73%)

15:34
11/13/19
11/13
15:34
11/13/19
15:34
Options
ProPetro Holding options imply 26.4% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

PTON

Peloton

$24.60

-0.12 (-0.49%)

15:21
11/13/19
11/13
15:21
11/13/19
15:21
Periodicals
Peloton said to plan cheaper treadmill, rowing machine for 2020, Bloomberg says »

Peloton (PTON) is said to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 09

    Dec

TNK

Teekay Tankers

$2.02

-0.055 (-2.66%)

15:19
11/13/19
11/13
15:19
11/13/19
15:19
Options
Teekay Tankers options imply 19.5% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
11/13/19
11/13
15:17
11/13/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
11/13/19
11/13
15:16
11/13/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$147.12

8.56 (6.18%)

, NFLX

Netflix

$284.22

-7.79 (-2.67%)

15:04
11/13/19
11/13
15:04
11/13/19
15:04
On The Fly
Disney higher as Disney+ streaming service hits 10M subscribers after one day »

On Tuesday morning, The…

DIS

Disney

$147.12

8.56 (6.18%)

NFLX

Netflix

$284.22

-7.79 (-2.67%)

AAPL

Apple

$264.03

2.14 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 09

    Dec

  • 10

    Dec

NTAP

NetApp

$60.15

0.03 (0.05%)

15:04
11/13/19
11/13
15:04
11/13/19
15:04
Options
NetApp options imply 14.0% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 20

    Nov

  • 12

    Dec

PDLB

PDL Community Bancorp

$13.78

-0.21 (-1.50%)

15:01
11/13/19
11/13
15:01
11/13/19
15:01
Hot Stocks
PDL Community Bancorp to repurchase up to 878,835 shares of common stock »

PDL Community Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRK

Comstock Resources

$6.86

-0.02 (-0.29%)

, CHK

Chesapeake

$0.70

0.0303 (4.52%)

14:56
11/13/19
11/13
14:56
11/13/19
14:56
Periodicals
Jerry Jones confirms to Bloomberg that Comstock in talks for Chesapeake assets »

Comstock Resources'…

CRK

Comstock Resources

$6.86

-0.02 (-0.29%)

CHK

Chesapeake

$0.70

0.0303 (4.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INST

Instructure

$50.73

2.75 (5.73%)

14:55
11/13/19
11/13
14:55
11/13/19
14:55
Periodicals
Instructure exploring sale following activist pressure, Bloomberg says »

Instructure is weighing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 09

    Dec

ILMN

Illumina

$297.27

1.39 (0.47%)

14:55
11/13/19
11/13
14:55
11/13/19
14:55
Conference/Events
Illumina participates in a conference call with SVB Leerink »

Conference call with Dr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

CSCO

Cisco

$48.52

0.14 (0.29%)

14:49
11/13/19
11/13
14:49
11/13/19
14:49
Options
Cisco options imply 7.1% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 09

    Dec

  • 10

    Dec

LPSN

LivePerson

$34.88

-0.29 (-0.82%)

14:48
11/13/19
11/13
14:48
11/13/19
14:48
Conference/Events
LivePerson management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 10

    Dec

ESTA

Establishment Labs

$23.77

0.17 (0.72%)

14:46
11/13/19
11/13
14:46
11/13/19
14:46
Conference/Events
Establishment Labs management to meet with Jefferies »

Meetings to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

CLDR

Cloudera

$8.47

-0.195 (-2.25%)

14:45
11/13/19
11/13
14:45
11/13/19
14:45
Options
Cloudera call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

DIS

Disney

$145.75

7.19 (5.19%)

14:41
11/13/19
11/13
14:41
11/13/19
14:41
Recommendations
Disney analyst commentary  »

Disney price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$145.31

6.75 (4.87%)

14:38
11/13/19
11/13
14:38
11/13/19
14:38
Hot Stocks
Disney confirms 10M sign-ups for Disney+ since yesterday's launch »

Disney+, the streaming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:35
11/13/19
11/13
14:35
11/13/19
14:35
General news
Fedspeak continues Thursday, headlined by Chair Powell »

Fedspeak continues…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.